Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

Phase 2

Completed

• Conditions: Schizophrenia

• Registration Number: NCT00036127
• Lead Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Brief Summary

Study to learn if the alternate formulation is effective in agitated schizophrenic patients

Detailed Description

Not available

Study Timeline

• Study Start: 2002-04
• Study First Submitted: 2002-05-07
• Study First Submitted QC: 2002-05-08
• Study First Posted: 2002-05-09
• Primary Completion: 2003-01
• Study Completion: 2003-01
• Status Verified: 2007-09
• Last Update Submitted: 2013-11-07
• Last Update Posted: 2013-11-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Agitated schizophrenic patients

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (2)

Local Instituton; 🇺🇸 Hoffman Estates, Illinois, United States

Local Institution; 🇺🇸 Milwaukee, Wisconsin, United States